5 PHARMACEUTICALS, PARTICULARLY DEVELOPED ON THE BASIS OF BIOTECHNOLOGICAL METHODS, PARTICULARLY FOR THE TREATMENT OF DIABETES I OR II; ARTERIOSCLEROSIS; HEART ATTACKS; HEART FAILURES; STROKES; PARKINSON'S DISEASE; ALZHEIMER'S DISEASE; LEUKEMIA; SOLID TUMORS, PARTICULARLY BRAIN, LIVER, PANCREAS, LUNG OR INTESTINAL TUMORS; INFECTIOUS DISEASES, PARTICULARLY BACTERIAL, VIRAL OR PROTOZOOLOGICAL INFECTIOUS DISEASES, PARTICULARLY TUBERCULOSIS, HIV, MALARIA, LEISHMANIASIS; AUTOMIMMUNIE DISEASES, PARTICULARLY TEN, RHEUMATIC ARTHRITIS, LUPUS ERYTHEMATOSUS, MULTIPLE SCLEROSIS; NEUROLOGICAL DISORDERS; METABOLIC DISORDERS; DISORDERS BASED ON PATHOLOGICAL INFLAMMATORY REACTIONS